Navigation Links
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Date:5/3/2012

GUANGZHOU, China, May 3, 2012 /PRNewswire-Asia/ -- Johnson & Johnson (China) Investment Ltd. today announced it has acquired Guangzhou Bioseal Biotechnology Co., Ltd. (Bioseal) a privately held biopharmaceutical company specializing in the design, development and commercialization of a porcine plasma-derived biologic product for controlling bleeding during surgery. The acquisition was completed after obtaining all necessary Chinese Government approvals. Financial terms of the transaction are not being disclosed.

"This transaction reinforces our commitment to China and delivering innovative medical device solutions to the Chinese market," said Xie Wen Jian President of Johnson & Johnson Medical China. "We are very pleased to add the BIOSEAL™ brand to our growing portfolio of hemostasis products in China and we look forward to working with our new Bioseal colleagues to bring their innovative products to more physicians and patients."

Bioseal manufactures a porcine-derived fibrin sealant, BIOSEAL™, currently the only porcine plasma-derived fibrin sealant approved for use in China. Fibrin sealants are used by surgeons as an adjunct to hemostasis for use in patients undergoing surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.

Bioseal will work closely with Ethicon, Inc., a Johnson & Johnson Company, which offers the world's most complete line of absorbable hemostats with a commitment to advancing the future of biosurgery beyond hemostasis, to seal leaks, join structures and enhance healing. Ethicon biosurgery brands already on the market in China include SURGICEL® and SURGIFLO®.

"By adding Bioseal to the existing line of Ethicon hemostasis products sold in China, we aspire to shape the broader biosurgery market in Asia by providing physicians and their patients with an even greater variety of innovative and clinical-based solutions to add
'/>"/>

SOURCE Johnson & Johnson (China) Investment Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of XARELTO® (rivaroxaban) Phase 3 Clinical Data Presented at the American College of Cardiologys Annual Scientific Sessions
2. CNJ Enterprises: DePuy ASR Hip Implant Recall Large Contributor to Johnson & Johnsons $2.9 Bil Charge for 4th Quarter 2011
3. Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:
4. Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2011 Financial Results
5. Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference
6. Johnson & Johnson Reports 2011 Third-Quarter Results
7. Johnson & Johnson to Host Analyst Conference Call on Third-Quarter Results
8. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent
9. McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture
10. Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World
11. Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 IRIDEX Corporation (Nasdaq: IRIX ... six months ended June 28, 2014.  , Revenues ... 15% from $9.2 million in the 2013 second quarter and ... 2014. Revenues for the first six months of 2014 were ... six months of last year. , Gross margin for ...
(Date:7/31/2014)... Xencor Inc. (NASDAQ: XNCR ), a ... the treatment of autoimmune diseases, asthma and allergic ... the second quarter ended June 30, 2014 and provided ... "In the second quarter, we presented preclinical data ... (ATS) demonstrating three novel mechanisms of action of ...
(Date:7/31/2014)... July 31, 2014 Nektar Therapeutics (Nasdaq: ... quarter ended June 30, 2014. Cash and ... million as compared to $309.1 million at March 31, 2014."The ... Nektar as we look forward to significant milestones for a ... President and Chief Executive Officer of Nektar. "The first of ...
Breaking Medicine Technology:IRIDEX Reports 2014 Second Quarter, Six-Month Results 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 4IRIDEX Reports 2014 Second Quarter, Six-Month Results 5IRIDEX Reports 2014 Second Quarter, Six-Month Results 6IRIDEX Reports 2014 Second Quarter, Six-Month Results 7Xencor Reports Second Quarter 2014 Financial Results 2Xencor Reports Second Quarter 2014 Financial Results 3Xencor Reports Second Quarter 2014 Financial Results 4Xencor Reports Second Quarter 2014 Financial Results 5Xencor Reports Second Quarter 2014 Financial Results 6Xencor Reports Second Quarter 2014 Financial Results 7Xencor Reports Second Quarter 2014 Financial Results 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14
(Date:8/1/2014)... Barbara Bronson Gray HealthDay Reporter ... and work in manufacturing jobs may have significantly less endurance than ... study of 32 people -- half were obese, half were of ... that were about 60 percent longer. Obesity also was associated ... Being older -- 50 to 65 years of age ...
(Date:8/1/2014)... 1, 2014 (HealthDay News) -- Almost 140 people ... transportation in the United States. But there ... catastrophes, Dawne Gardner, injury prevention coordinator at Cincinnati ... said in a medical center news release. ... to school, it,s important for parents and children ...
(Date:8/1/2014)... Summer is here, and with it comes ... summer, and they can be a pain for dogs. Animal ... all their customers get rid of ticks and prevent them ... in the summer, which is why they are so active ... and woodland areas and carry a number of diseases, including ...
(Date:8/1/2014)... 1, 2014Lesbian, gay, bisexual, and transgender individuals who want ... as some of their heterosexual and cisgendered peers, such ... additional physiological and legal challenges to become parents. ... assisted reproduction options is presented in the article " ... published in LGBT Health , a ...
(Date:8/1/2014)... 01, 2014 Growing prevalence of ... healthcare reforms are boosting healthcare market growth, although ... discounts and increasing generic consumption is a major ... million in 2013, having grown at a Compound ... The implementation of the Health Transformation Program (Saglikta ...
Breaking Medicine News(10 mins):Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:Expert Offers School Bus Safety Tips 2Health News:Tis the Season for Tick Prevention 2Health News:Advances in assisted reproduction create more options and new legal issues for LGBT couples 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4
... molecule called RBP4 (retinol binding protein 4) is an indication ... insulin resistance //, the main cause of type 2 ... a recent study. ,Researchers at Beth Israel Deaconess ... target, and also offers an early method of identifying individuals ...
... suspected connection between MMR(measles, mumps and rubella) vaccine and bowel ... of the vaccine, despite the assurances extended by government ... is to be initiated by the Department of Health, and ... were affected by the vaccine. The offer comes after a ...
... the globe die every year of environmental-linked diseases, ... ,The four main diseases influenced by poor ... various forms of unintentional injuries and malaria, said ... through Healthy Environments", underlined that over 40 percent ...
... of HIV positive patients in Bihar, a high profile ... state legislature and those connected// with AIDS awareness programme ... a more forceful drive against the dreaded disease, official ... inaugurate the day-long brainstorming session on June 24 here, ...
... their lives the older they get, with the greatest level of ... study//. ,Researchers at the VA Ann Arbor Healthcare System ... - the first group between 21 and 40 years age, and ... researchers asked the participants to rank their own happiness on a ...
... fatigue, bodily changes and stress all links with psychological approach ... the recent issue of Perspectives// on Psychological Science elaborates. ... to view hills as steeper when we are tired, less ... greater and the distance to the ground appears further when ...
Cached Medicine News:Health News:A New Marker For Type-2 Diabetes ? 2Health News:13 million environment-linked deaths every year: WHO 2
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
20 GA TITANIUM RETINAL FORCEPS...
Medicine Products: